
Quadrille Capital
Description
Quadrille Capital is an independent private investment firm with a dual investment strategy, operating from offices in Paris and San Francisco. Established in 2007, the firm primarily manages capital for institutional investors and family offices, overseeing a substantial portfolio. As of December 31, 2023, Quadrille Capital managed over $4.5 billion in assets, reflecting its significant presence in the private investment landscape. Their approach combines investing in a diversified portfolio of venture capital, growth equity, and buyout funds with making direct co-investments in promising companies.
The firm's direct investment strategy is concentrated on high-growth technology companies, with a geographical focus primarily on the United States and Europe. Quadrille Capital typically engages in later-stage funding rounds, specifically targeting Series B, C, and D investments. This strategic focus allows them to partner with companies that have demonstrated product-market fit and are poised for significant scaling.
When making direct investments, Quadrille Capital commits substantial capital, with typical first cheque sizes ranging from $10 million to $50 million per company. Their sector interests are diverse within technology, encompassing areas such as enterprise software, fintech, healthcare IT, and consumer internet. By co-investing alongside the fund managers they back, Quadrille Capital leverages its extensive network and deep industry expertise to support the growth and development of its portfolio companies, aiming for long-term value creation.
Investor Profile
Quadrille Capital has backed more than 49 startups, with 3 new investments in the last 12 months alone. The firm has led 10 rounds, about 20% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in United States, France, Spain.
- Strong thematic focus on Health Care, E-Commerce, Medical.
- Led 2 rounds in the past year.
- Typical check size: $10M – $50M.
Stage Focus
- Series B (27%)
- Series Unknown (24%)
- Series C (18%)
- Series D (10%)
- Series E (6%)
- Series A (4%)
- Private Equity (4%)
- Post Ipo Equity (4%)
- Debt Financing (2%)
Country Focus
- United States (53%)
- France (14%)
- Spain (6%)
- Germany (6%)
- Sweden (6%)
- Czech Republic (6%)
- United Kingdom (2%)
- Austria (2%)
- Canada (2%)
- Luxembourg (2%)
Industry Focus
- Health Care
- E-commerce
- Medical
- Software
- Medical Device
- Biotechnology
- Food And Beverage
- Internet
- Marketplace
- Retail
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.